- Research article
- Open Access
Elcatonin attenuates disuse osteoporosis after fracture fixation of tubular bone in rats
© Ji et al. 2015
- Received: 27 April 2015
- Accepted: 26 June 2015
- Published: 3 July 2015
Elcatonin (ECT) is used to prevent and treat osteoporosis. However, little is known about its effect on the disuse osteoporosis (DOP). The aim of this study is to evaluate the effect of ECT on DOP caused by fracture fixation.
Forty-five male Sprague-Dawley (SD) rats, aged 6 weeks, were randomly allocated into three groups: the control group without surgery and elcatonin treatment (CTR, n = 15), the surgery group without elcatonin treatment (SUR, n = 15), and the surgery group which received elcatonin subcutaneously (SUR + ECT, n = 15). Surgery was produced by cutting the midshaft of the right femur transversely, fixing with stainless intramedullary needle, and immobilizing the right leg. All the proximal tibias from the random five rats in each group were harvested and investigated by evaluating bone mineral density (BMD), X-ray images, and histological staining respectively at the 4th, 8th, and 12th weeks after surgery.
Both of the SUR and SUR + ECT groups obviously exhibited lower BMD values compared to the CTR group; however, the SUR + ECT group showed significantly higher BMD values (p < 0.001, p < 0.05, and p < 0.05) than the SUR group at each time point after surgery. Moreover, similar changes were observed between these groups when examining the radiographs and hematoxylin and eosin (HE) staining.
Elcatonin attenuates disuse osteoporosis after fractures in rats, which may provide a new avenue to prevent and treat disuse osteoporosis after surgery in clinic.
- Disuse osteoporosis
- Bone fracture
Disuse osteoporosis (DOP) is defined as localized or generalized bone loss due to skeletal mechanical unloading [1–3], such as long-term therapeutic bed rest , immobilization due to motor paralysis from injury of the central nervous system  or peripheral nerves, application of cast to treat fractures , and prolonged weightlessness during spaceflight . In clinic practice, DOP is inevitable when plaster fixation is applied to stabilize the fracture and immobilize the bones or joints after the surgery [3, 6], which results in a decrease of bone strength and an increased risk of secondary fracture. Since the pathophysiology of DOP is still unclear, the treatments, for instance, therapeutic exercise, electrical therapy, calcium, vitamin D, and bisphosphonates, are not quite satisfactory so far. However, it is reported that low or loss of mechanical stress on bones induces acceleration of osteoclast-mediated bone resorption and inhibition of osteoblast-mediated bone formation and finally leads to bone loss [1, 3, 8]. Therefore, anti-resorptive agents were considered to prevent or treat DOP.
Elcatonin (ECT) is a physicochemically and biologically stable synthetic derivative of eel calcitonin and which consists of 31 amino acids with stable ethylene linkage as a result of substituting the intra-chain disulfide bond of calcitonin [9, 10]. It has been reported that ECT suppresses bone resorption through direct action on the calcitonin receptors of osteoclasts [11, 12] and acts with potent analgesic effect [12–15]. Moreover, data showed that ECT did not delay the overall fracture healing process compared to alendronate which strongly suppressed callus remodeling in cynomolgus monkeys . ECT and salmon calcitonin have been worldwide used for the prophylaxis and treatment of osteoporosis [14, 16, 17], but a beneficial effect of ECT on bone has not been evaluated in surgically induced DOP yet.
Therefore, in the present study, we investigated the effects of the administration of elcatonin on the distal bone away from the fracture fixation of femur in rats which were rodent models of surgically-induced DOP.
Fifty male Sprague-Dawley rats, aged 6 weeks in this study, were provided by Laboratory Animal Center of Xi’an Jiaotong University. All rats were housed individually in cages in a standard animal room maintained at a temperature of 22 ± 3 °C, a humidity of 50 ± 20 %, and a 12-h light-dark cycle, and ventilated ten or more times per hour. The animals were allowed access to food and tap water ad libitum during the entire experiment period. All animal procedures were conducted in accordance with the Principles of Laboratory Animal Care established by National Institutes of Health (NIH) and guidelines from Laboratory Animal Care Committee of Xi’an Jiaotong University.
Besides the five rats that were harvested and followed by histological staining procedure before surgery, other 45 animals were randomly allocated into three groups with 15 each: the control group without surgery and ECT treatment (CTR), the surgery group without ECT treatment (SUR), and the surgery group which received ECT subcutaneously (SUR + ECT). Body weight of the animals was recorded monthly. Surgery was conducted after 3-day feeding by cutting the midshaft of the right femur transversely, fixing with stainless intramedullary needle, and immobilizing the right hind limb via tibia-tail fixation. All the femurs, knee joints, and tibias from the random five rats in each group were respectively harvested at the 4th, 8th, and 12th weeks after surgery, and the proximal tibias were investigated by evaluating bone mineral density (BMD), X-ray images, and histological staining.
Establishment of the animal model
- 1)Post-osteotomy fixation: The osteotomy and fixation were made in the right femur of each rat according to the method of Mathavan et al. . Under standard sterile conditions, a lateral approach at the middle of femur was made and the periosteum was circumferentially incised. A transverse fracture was performed at the middiaphysis with an oscillating power saw, then the fracture site was stabilized and fixed by an intramedullary steel needle with a diameter of 1.2 mm (Fig. 1a). The incision was precisely closed with sterilized sutures.
Tibia-tail fixation: After the femoral fracture and internal fixation were accomplished, the right hind limbs of animals in the SUR and SUR + ECT groups were immobilized against the tails with simple external fixation based on the operation previously described by Zarzhevsky et al. . Briefly, under anesthesia, the right ankles of animals were drilled, and a steel wire with diameter of 1.0 mm was inserted and connected to the tail at a distance of 1.5 cm from the anus. All rats were able to stand with their other three limbs after anesthesia resuscitation (Fig. 1b). The wires were removed 8 weeks after the surgery in the SUR and SUR + ECT groups. The external fixators were sterilized by iodophors and checked daily.
Following the operations, ECT (Sidinuo, Luye Pharma Group Co. Ltd., Shandong Province, China) was administered at 15 U/kg three times a week  in SUR + ECT group, subcutaneously for 12 weeks. The CTR and SUR groups correspondingly administered the vehicles of the ECT injections.
Bone samples from the right proximal tibias were subsequently evaluated via radiographic assessment, BMD measurement, and histology.
Antero-posterior radiographs were obtained from all animals via a clinical X-ray system at a condition of Voltage/Current = 52 kV/1.60 mA. The radiographs from the proximal tibias were visually assessed for the degrees of osteoporosis through double-blinded reviewing by two orthopedic surgeons. Compared to the CTR group, each bone from SUR or SUR + ECT group was scored as 0 (almost similar density), 0.5 (mildly lower density or thinner bone cortex), 1 (mildly lower density and thinner bone cortex), or 2 (severely lower density or/and thinner bone cortex).
BMD value was measured for the proximal third of right tibia which primarily consisted of cancellous bone via dual-energy X-ray absorptiometry (DXA) (Norland XR-46, Norland/Swissray, USA) at a scan pitch of 1.5 mm and a scan speed of 60 mm/s.
Followed by tissue collection and decalcification with 10 % EDTA for 3 weeks, the right tibias from all groups were commenced with chemical fixation in 4 % formaldehyde for 48 h. Subsequently, the samples were dehydrated in graded ethanol, cleared in xylene, immerged in molten paraffin at 60 °C overnight, and embedded into wax block. Transverse sections of 4-μm thickness were cut by a microtome (RM2125RT, Leica Biosystems Nussloch GmbH, Germany) and stained with hematoxylin and eosin following standard protocol. The areas of bone trabeculae were quantified with Image-Pro Plus software (Version 6.0, Media Cybernetics, Inc., USA). Quantitative scoring of the histology was performed to determine the density of cancellous bone. Two blinded independent reviewers performed the analysis of all samples and the measurements were averaged.
Data were expressed as the mean ± standard error of the mean (SEM). One-way ANOVA analysis was carried out to analyze for differences among the groups by SPSS (Version 22.0, SPSS/IBM Corporation, USA), and both Tukey HSD and Bonferroni tests were applied as a post hoc test if statistical significance was determined. A value of probability level (p) which was less than 0.05 was considered statistically significant.
Using a well-established open rat model induced by post-osteotomy fixation and tibia-tail immobilization, our present study postulates and confirms the hypothesis that the administration of ECT attenuates disuse osteoporosis on the distal bone away from fracture fixation in rats. It is known that ECT is presently used worldwide for preventing and treating the osteoporosis, however, we were the first to investigate the effects of ECT on the post-surgery DOP, and three observations in particular demonstrated that ECT notably suppressed the bone loss at the 4th, 8th, and 12th weeks after surgery. The first observation was in relation to radiographic assessment where the SUR + ECT group exhibited higher density and thicker bone cortex in the proximal tibia compared to the SUR group. Radiographic outcomes is advantageous only if it is matched with BMD values, and this was substantiated with the second observation from the BMD measures where the values in the SUR + ECT group increased smoothly along with the CTR group. And quantitative histology showed an increased trabecular percentage in the SUR + ECT group compared to that in the SUR group. Thus, through manipulation of the anti-resorptive influences of ECT on surgery-induced DOP, an effective anti-osteoporosis outcome was achieved.
The technique of fracture fixation employed in our study [18, 20] is analogous to a common clinical method used in the treatment of femoral fractures, and the tibia-tail fixation [19, 21] is applied for establishing a model of unloading on the musculoskeletal system as the cast immobilization after fracture surgery in clinic.
In addition, the concerns of anti-osteoporosis effects by ECT have been interpreted in the literatures [9, 10, 22–24]. For instance, Iwamoto et al. presented data from a 5-year-period study demonstrating a sustainable role of ECT in post-menopausal women with osteoporosis . In addition, another study in post-menopausal osteoporotic women confirmed the active effects of short-term combined treatment with bisphosphonate and ECT on lumbar BMD and bone turnover with back pain [23, 24]. Furthermore, mild suppression of callus remodeling by ECT did not impair overall fracture healing process in the femoral fracture model of cynomolgus monkeys , whereas ECT facilitated osteoblast proliferation in the fracture site and suppressed the systemic acceleration of bone resorption without affecting cortical bone regeneration after drill-hole injuries in mice . According to the work above, it was considered to study the influence of ECT as an alternative chemical on the post-fracture DOP in rats without delaying the fracture healing.
During the 12 weeks of treatment, a marked lower body weight was observed both in the SUR and SUR + ECT groups (Fig. 2), which interpreted that the administration of ECT did not affect the weight changes of animals after surgery as body weight is a general index of the health of an animal . And this might be attributed to a decrease in food intake after surgery.
As the plain X-ray film reveals important features of disuse osteoporosis affecting tubular bones, thinning of cortices, increased radiolucency, and rarefication of bone trabeculae [3, 18, 25], the potent anti-osteoporosis effectiveness of ECT in sustaining the bony density were clearly demonstrated in the results from the radiographic analysis where the presence of ECT produced less rarefication of bone in the proximal tibia at each time point. Moreover, with the addition of ECT to the animals after surgery, not only did the combination of fracture reliably and quickly achieve union but also did the features of bone substance in femurs attain nearly on par with the non-operated control femurs at the 12th week post-surgery, which was in line with the conclusion described previously .
Since the technology of dual-energy X-ray absorptiometry (DXA) has been used to measure regional BMD  which has been described as a surrogate measure of bone strength , BMD measurements have developed and provided the basis for diagnosing osteoporosis, predicting the risk of osteoporotic fracture, and evaluating the therapeutic effects of drugs . In our study, the BMDs in the proximal third of tibia from the SUR group at the 4th, 8th, and 12th weeks were all much lower than those in the normal rat, at the same time, it was observed that the therapy with ECT could increase the BMDs to a statistically undifferentiated level as the CTR group. In particular, the BMD values in the proximal third of tibia from non-ECT-treated rats went down dramatically at the 4th week after the fracture operation and tibia-tail fixation. This indicates that the administration of ECT we used in present study can suppress the surgically-induced DOP effectively both in the former 8 weeks with immobilization and in the later 4 weeks without.
Similar to our observations above, histological staining and analysis of the metaphysis from ECT-treated tibias confirmed significant increases in the quantitative trabeculae at the 4th, 8th, and 12th weeks after surgery compared to the SUR group. Under the circumstance of immobilization, the osteoclast activities increased because of the decreased mechanical stimulus . Although its precise physiological role in the rats is not well understood, so far it is known that ECT inhibits bone resorption by binding to the calcitonin-like receptors on the osteoclast membrane, thus, destroying osteoclast activities [12, 28]. Based on our findings, we speculate that ECT might suppress osteoclast effectively so that there is no excessive bone resorption in osteogenesis or bone remodeling after the surgery mentioned in our work. Therefore, ECT could not only decrease the bone resorption but also slightly promote the ossification in the first 4 weeks after surgery.
Additionally, based on radiological, BMD, and histomorphometric evaluation of proximal tibia away from fractured femur without immobilization from 8 to 12 weeks in rats treated with ECT, we concluded that ECT might still sustain the osteogenic process and at least had no negative effect on the intrinsic properties of femurs and tibias.
There are several limitations in the current study. Firstly, it is an exclusively in vivo experiment for prophylactic and therapeutical effects of ECT on the surgically-induced DOP in animal models. In addition, a limited number of time points prohibited a more detailed observation of the stages of DOP and the ideal time for administration of ECT. Finally, anti-resorptive agents are generally administrated for elderly patients with osteoporosis clinically, and the animal models should provide clinically related information. Therefore, the elderly animals should be utilized to further elucidate a more complete understanding of the effect of ECT on the DOP after the fracture fixation in the future.
The present study highlights that elcatonin can attenuate surgically induced bone loss and deterioration of trabeculae in the distal bone from fracture in rats, which may serve as an alternative medicine for the prophylaxis and treatment of disuse osteoporosis after surgery in clinic practice. In the future study, the molecular mechanisms of related protein and cytokine regulation behind the results and examinations need further investigation.
We would like to thank Dr. Enqi Liu and his staff in the Laboratory Animal Center of Xi’an Jiaotong University for their excellent and expert animal care. Our thanks also go to Prof. Kaifang Zhang (Department of Orthopaedics, the Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University) for his valuable suggestions. The authors also acknowledge the facilities as well as technical assistance from the staff in the Department of Radiology in Shaanxi Provincial People’s Hospital, Xi’an, China.
- Alexandre C, Vico L. Pathophysiology of bone loss in disuse osteoporosis. Joint Bone Spine. 2011;78(6):572–6. doi:10.1016/j.jbspin.2011.04.007.PubMedView ArticleGoogle Scholar
- Qi W, Yan YB, Lei W, Wu ZX, Zhang Y, Liu D, et al. Prevention of disuse osteoporosis in rats by Cordyceps sinensis extract. Osteoporos Int. 2012;23(9):2347–57. doi:10.1007/s00198-011-1842-4.PubMedView ArticleGoogle Scholar
- Takata S, Yasui N. Disuse osteoporosis. J Med Invest. 2001;48(3–4):147–56.PubMedGoogle Scholar
- Wang H, Wan Y, Tam KF, Ling S, Bai Y, Deng Y, et al. Resistive vibration exercise retards bone loss in weight-bearing skeletons during 60 days bed rest. Osteoporos Int. 2012;23(8):2169–78. doi:10.1007/s00198-011-1839-z.PubMedView ArticleGoogle Scholar
- Garland DE, Adkins RH, Stewart CA, Ashford R, Vigil D. Regional osteoporosis in women who have a complete spinal cord injury. J Bone Joint Surg Am. 2001;83-A(8):1195–200.PubMedGoogle Scholar
- Kannus P, Jarvinen M, Sievanen H, Oja P, Vuori I. Osteoporosis in men with a history of tibial fracture. J Bone Miner Res. 1994;9(3):423–9. doi:10.1002/jbmr.5650090319.PubMedView ArticleGoogle Scholar
- Collet P, Uebelhart D, Vico L, Moro L, Hartmann D, Roth M, et al. Effects of 1- and 6-month spaceflight on bone mass and biochemistry in two humans. Bone. 1997;20(6):547–51.PubMedView ArticleGoogle Scholar
- Lau RY, Guo X. A review on current osteoporosis research: with special focus on disuse bone loss. J Osteoporos. 2011;2011:293808. doi:10.4061/2011/293808.PubMed CentralPubMedView ArticleGoogle Scholar
- Manabe T, Mori S, Mashiba T, Cao Y, Kaji Y, Iwata K, et al. Eel calcitonin (elcatonin) suppressed callus remodeling but did not interfere with fracture healing in the femoral fracture model of cynomolgus monkeys. J Bone Miner Metab. 2009;27(3):295–302. doi:10.1007/s00774-009-0046-x.PubMedView ArticleGoogle Scholar
- Katae Y, Tanaka S, Sakai A, Nagashima M, Hirasawa H, Nakamura T. Elcatonin injections suppress systemic bone resorption without affecting cortical bone regeneration after drill-hole injuries in mice. J Orthop Res. 2009;27(12):1652–8. doi:10.1002/jor.20920.PubMedView ArticleGoogle Scholar
- Chambers TJ, Moore A. The sensitivity of isolated osteoclasts to morphological transformation by calcitonin. J Clin Endocrinol Metab. 1983;57(4):819–24. doi:10.1210/jcem-57-4-819.PubMedView ArticleGoogle Scholar
- Ogawa K, Hori M, Takao R, Sakurada T. Effects of combined elcatonin and alendronate treatment on the architecture and strength of bone in ovariectomized rats. J Bone Miner Metab. 2005;23(5):351–8. doi:10.1007/s00774-005-0612-9.PubMedView ArticleGoogle Scholar
- Ito A, Kumamoto E, Takeda M, Shibata K, Sagai H, Yoshimura M. Mechanisms for ovariectomy-induced hyperalgesia and its relief by calcitonin: participation of 5-HT1A-like receptor on C-afferent terminals in substantia gelatinosa of the rat spinal cord. J Neurosci. 2000;20(16):6302–8.PubMedGoogle Scholar
- Knopp JA, Diner BM, Blitz M, Lyritis GP, Rowe BH. Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int. 2005;16(10):1281–90. doi:10.1007/s00198-004-1798-8.PubMedView ArticleGoogle Scholar
- Yoh K, Tanaka K, Ishikawa A, Ishibashi T, Uchino Y, Sato Y, et al. Health-related quality of life (HRQOL) in Japanese osteoporotic patients and its improvement by elcatonin treatment. J Bone Miner Metab. 2005;23(2):167–73. doi:10.1007/s00774-004-0556-5.PubMedView ArticleGoogle Scholar
- Hongo M, Miyakoshi N, Kasukawa Y, Ishikawa Y, Shimada Y. Additive effect of elcatonin to risedronate for chronic back pain and quality of life in postmenopausal women with osteoporosis: a randomized controlled trial. J Bone Miner Metab. 2014. doi:10.1007/s00774-014-0603-9.Google Scholar
- Farmer RP, Herbert B, Cuellar DO, Hao J, Stahel PF, Yasui R, et al. Osteoporosis and the orthopaedic surgeon: basic concepts for successful co-management of patients’ bone health. Int Orthop. 2014;38(8):1731–8. doi:10.1007/s00264-014-2317-y.PubMedView ArticleGoogle Scholar
- Mathavan N, Bosemark P, Isaksson H, Tagil M. Investigating the synergistic efficacy of BMP-7 and zoledronate on bone allografts using an open rat osteotomy model. Bone. 2013;56(2):440–8. doi:10.1016/j.bone.2013.06.030.PubMedView ArticleGoogle Scholar
- Zarzhevsky N, Coleman R, Volpin G, Fuchs D, Stein H, Reznick AZ. Muscle recovery after immobilisation by external fixation. J Bone Joint Surg Br. 1999;81(5):896–901.PubMedView ArticleGoogle Scholar
- Bonnarens F, Einhorn TA. Production of a standard closed fracture in laboratory animal bone. J Orthop Res. 1984;2(1):97–101. doi:10.1002/jor.1100020115.PubMedView ArticleGoogle Scholar
- Shen WW, Zhao JH. Pulsed electromagnetic fields stimulation affects BMD and local factor production of rats with disuse osteoporosis. Bioelectromagnetics. 2010;31(2):113–9. doi:10.1002/bem.20535.PubMedGoogle Scholar
- Iwamoto J, Takeda T, Ichimura S, Uzawa M. Effects of 5-year treatment with elcatonin and alfacalcidol on lumbar bone mineral density and the incidence of vertebral fractures in postmenopausal women with osteoporosis: a retrospective study. J Orthop Sci. 2002;7(6):637–43. doi:10.1007/s007760200114.PubMedView ArticleGoogle Scholar
- Iwamoto J, Uzawa M, Sato Y, Takeda T, Matsumoto H. Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis. Ther Clin Risk Manag. 2009;5(3):499–505.PubMed CentralPubMedView ArticleGoogle Scholar
- Takakuwa M, Iwamoto J. Elcatonin in combination with risedronate is more effective than risedronate alone for relieving back pain in postmenopausal women with osteoporosis. Biol Pharm Bull. 2012;35(7):1159–65.PubMedView ArticleGoogle Scholar
- Wey A, Cunningham C, Hreha J, Breitbart E, Cottrell J, Ippolito J, et al. Local ZnCl2 accelerates fracture healing. J Orthop Res. 2014;32(6):834–41. doi:10.1002/jor.22593.PubMedView ArticleGoogle Scholar
- Bouxsein ML. Mechanisms of osteoporosis therapy: a bone strength perspective. Clin Cornerstone. 2003;Suppl 2:S13–21.PubMedView ArticleGoogle Scholar
- Miller PD. Guidelines for the diagnosis of osteoporosis: T-scores vs fractures. Rev Endocr Metab Disord. 2006;7(1–2):75–89. doi:10.1007/s11154-006-9006-0.PubMedGoogle Scholar
- Suzuki H, Nakamura I, Takahashi N, Ikuhara T, Matsuzaki K, Isogai Y, et al. Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts. Endocrinology. 1996;137(11):4685–90. doi:10.1210/endo.137.11.8895334.PubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.